Role of oxidative stress in neurodegeneration: Recent developments in assay methods for oxidative stress and nutraceutical antioxidants

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 28, Issue 5, 2004, Pages 771-799

  Cui, Ke ^a   Luo, Xiaoling ^a   Xu, Keyi ^a   Ven Murthy, M R ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

Antioxidants; Curcumin; Hydroxyl radicals; Lipid peroxidation; Lutein; Lycopene; Melatonin; Mitochondrial DNA; Neuropathology; Nutraceuticals; Oxidative stress; Polymerase chain reaction; Reactive oxygen species; Carotene

Indexed keywords

ANTIOXIDANT; BETA CAROTENE; CURCUMIN; LIPID; LYCOPENE; MELATONIN; MITOCHONDRIAL DNA; PROTEIN; REACTIVE OXYGEN METABOLITE; XANTHOPHYLL;

AGING; ALZHEIMER DISEASE; AMPLICON; AMYOTROPHIC LATERAL SCLEROSIS; BRAIN; BRAIN INJURY; CELL FUNCTION; CELL METABOLISM; CELL STRUCTURE; CEREBROSPINAL FLUID; CURCUMA LONGA; DEFENSE MECHANISM; DEGENERATIVE DISEASE; DIET SUPPLEMENTATION; DOWN SYNDROME; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LABORATORY; NERVE DEGENERATION; NEUROTRANSMITTER RELEASE; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW; SIGNAL TRANSDUCTION;

EID: 4444237686     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2004.05.023     Document Type: Article

References (174)

1. Abe M., Reiter R.J., Orhii P.H., Hara M., Poeggeler B., Barrow-Walden L.R. Inhibitory effect of melatonin on cataract formation in newborn rats: evidence of an antioxidative role for melatonin. J. Pineal Res. 17:1994;94-100
2. Ali S., Mann D.A. Signal transduction via the NF-kappaB pathway: a targeted treatment modality for infection, inflammation and repair. Cell Biochem. Funct. 22:2004;67-79
3. Annunziato L., Amoroso S., Pannaccione A., Cataldi M., Pignataro G., D'alessio A., Sirabella R., Secondo A., Sibaud L., Di Renzo G.F. Apoptosis induced in neuronal cells by oxidative stress: role played by caspases and intracellular calcium ions. Toxicol. Lett. 139:2003;125-133
4. Arbuzova S., Hutchin T., Cuckle H. Mitochondrial dysfunction and Down's syndrome. Bioassays. 24:2002;681-684
5. Arroyo P.L., Hatch-Pigott V., Mower H.F., Cooney R.V. Mutagenicity of nitric oxide and its inhibition by antioxidants. Mutat. Res. 281:1992;193-202
6. Aruoma O.I. Deoxyribose assay for detecting hydroxyl radicals. Methods Enzymol. 233:1994;57-66
7. Augustin W., Gellerich F., Wiswedel I., Evetodienko Y., Zinchenko V. Inhibition of cation efflux by antioxidants during oscillatory ion transport in mitochondria. FEBS Lett. 107:1979;151-154
8. Babior B.M., Takeuchi C., Ruedi J., Gutierez A., Wentworth P. Jr. Investigating antibody-catalyzed ozone generation by human neutrophils. Proc. Natl. Acad. Sci. U. S. A. 100:2003;3013-3015
9. Bandy B., Davison A.J. Mitochondrial mutations may increase oxidative stress: implications for carcinogenesis and aging? Free Radic. Biol. Med. 8:1990;523-539
10. Barlow-Walden L., Reiter R.J., Abe M., Pablos M.I., Menendez-Palaez A., Chen L.D., Poeggeler B. Melatonin stimulates brain glutathione peroxidase activity. Neurochem. Int. 26:1995;497-502
11. Bartlett G.R. Phosphorus assay in column chromatography. J. Biol. Chem. 234:1959;466-468
12. Beal M.F. Mitochondria, oxidative damage, and inflammation in Parkinson's disease. Ann. N.Y. Acad. Sci. 991:2003;120-131
13. Beckman J.S. The double edged role of nitric oxide in brain function and superoxide-mediated injury. J. Dev. Physiol. 15:1991;53-59
14. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. U. S. A. 87:1990;1620-1624
15. Beckman J.S., Carson M., Smith C.D. ALS, SOD and peroxinitrite. Nature. 364:1993;584
16. Beckman J.S., Chen J., Ischiropoulos H., Crow J.P. Oxidative chemistry of peroxynitrite. Methods Enzymol. 233:1994;229-240
17. Behl C., Davis J.B., Lesley R., Schubert D. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell. 77:1994;817-827
18. Beneveniste H., Drejer J., Schousboe A., Diemer N.H. Elevations of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem. 43:1984;1369-1374
19. Blomgren K., Zhu C., Hallin U., Hagberg H. Mitochondria and ischemic reperfusion damage in the adult and in the developing brain. Biochem. Biophys. Res. Comm. 304:2003;551-559
20. Boka G., Anglade P., Wallach D., Javoy-Agid F., Hirsch E.C. Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease. Neurosci. Lett. 172:1994;151-154
21. Bondy S.C. The relation of oxidative stress and hyperexcitation to neurological disease. Proc. Soc. Exp. Biol. Med. 208:1995;337-345
22. Bowling A.C., Mutisya E.M., Walker L.C., Price D.L., Cork L.C., Beal M.F. Age-dependent impairment of mitochondrial function in primate brain. J. Neurochem. 60:1993;1964-1967
23. Bowling A.C., Schulz J.B., Brown R.H.J., Beal M.F. Superoxide dismutase activity, oxidative damage and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J. Neurochem. 61:1993;2322-2325
24. Brink C.B., Harvey B.H., Bodenstein J., Venter D.P., Oliver D.W. Recent advances in drug action and therapeutics: relevance of novel concepts in G-protein-coupled receptor and signal transduction pharmacology. Br. J. Clin. Pharmacol. 57:2004;373-387
25. Brooksbank B.W.L., Martinez M., Balazs R. Altered composition of polyunsaturated fatty acylgroups in phosphoglycerides of Down's syndrome fetal brain. J. Neurochem. 44:1985;869-874
26. Calne D.B. The free radical hypothesis in idiopathic parkinsonism: evidence against it. Ann. Neurol. 32:1992;799-803
27. Cadenas E., Sies H. Low level chemiluminescence as an indicator of singlet molecular oxygen in biological systems. Methods Enzymol. 105:1984;221-231
28. Cairns N.J. Neuropathology. J. Neural Transm. 57:1999;61-74
29. Carney J.M., Floyd R.A. Protection against oxidative damage to CNS by a phenyl-tert-butyl nitrone (PBN) and other spin-trapping agents: a novel series of nonlipid free radical scavengers. J. Mol. Neurosci. 3:1991;47-57
30. Cash A.D., Perry G., Ogawa O., Raina A.K., Zhu X., Smith M.A. Is Alzheimer's disease a mitochondrial disorder? Neuroscientist. 8:2002;489-496
31. Chandrasekaran K., Giordano T., Brady D.R., Stoll J., Martin L.J., Rapoport S.I. Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease. Mol. Brain Res. 24:1994;336-340
32. Chatgilialoglu C., Asmus K.D.E. Sulfur-centered reactive intermediates in chemistry and biology. NATO-ASI Series, Series A. vol. 197:1990;Plenum Press, New York
33. Chiueh C.C., Miyake H., Peng M.T. Role of dopamine autoxidation, hydroxyl radical generation, and calcium overload in underlying mechanisms involved in MPTP-induced parkinsonism. Narabayashi H., Nagatsu T., Yanagisawa N., Mizuno Y. Advances in Neurology. vol. 60:1993;251-258 Raven Press, New York
34. Chomyn A., Attardi G. Mitochondrial mutations in aging and apoptosis. Biochem. Biophys. Res. Comm. 304:2003;519-529
35. Cochrane C.G. Cellular injury by oxidants. Am. J. Med. 92(Suppl. 3C):1991;S23-S30
36. Cochrane C.G. Mechanisms of oxidant injury of cells. Mol. Aspects Med. 12:1991;137-147
37. Cooper D.N., Hall C. Down's syndrome and the molecular biology of chromosome 21. Prog. Neurobiol. 30:1988;507-530
38. Corral-Debrinski M., Horton T., Lott M.T., Shoffner J.M., Beal M.F., Wallace D.C. Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age. Nat. Genet. 2:1992;324-329
39. Curnatte J.T., Babior B.M. Chronic granulomatous disease. Adv. Hum. Genet. 16:1987;229-297
40. Dawson V.L., Dawson T.M. Physiological and toxicological actions of nitric oxide in the central nervous system. Adv. Pharmacol. 34:1995;323-342
41. Dawson T.M., Dawson V.L. Molecular pathways of neurodegeneration in Parkinson's disease. Science. 302:2003;819-822
42. Dawson T.M., Dawson V.L., Snyder S.H. A novel neuronal messenger molecule in brain: the free radical, nitric oxide. Ann. Neurol. 32:1992;297-311
43. Dean R.T., Gieseg S., Davies M.J. Reactive species and their accumulation on radical damaged protein. Trends Biochem. Sci. 18:1993;437-441
44. Deng H., Hentati A., Tainer J.A., Iqbal Z., Cayabyab A., Hung W., Getzoff E.D., Hu P., Herzfeldt B., Roos R.P., Warner C., Deng D., Soriano E., Smyth C., Parge H.E., Ahmed A., Roses A.D., Hallewel R.A., Pericak-Vance M.A., Siddique T. Amyotrophic lateral sclerosis and structural defects in Cu, Zn superoxide dismutase. Science. 261:1993;1047-1051
45. di Mascio P., Sies H. Quantification of singlet oxygen generated by thermolysis of 3,3′-(1,4-naphthylidene)dipropionate. Monomol and dimol photoemission and the effects of 1,4-diazobocyclo[2,2,2]octane. J. Am. Chem. Soc. 111:1989;2909-2914
46. di Mascio P., Bechara E.J., Medeiros M.H., Briviba K., Sies H. Singlet molecular oxygen production in the reaction of peroxynitrite with hydrogen peroxide. FEBS Lett. 355:1994;287-289
47. Droge W. Oxidative stress and aging. Adv. Exp. Med. Biol. 543:2003;191-200
48. Dyrks T., Dyrks E., Hartmann T., Masters C., Beyreuther K. Amyloidogenicity of βA4 and βA4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation. J. Biol. Chem. 267:1992;18210-18217
49. Ebadi M., Iversen P.L., Hao R., Cerutis D.R., Rojas P., Happe H.K., Murrin L.C., Pfeiffer R.F. Expression and regulation of brain metallothionein. Neurochem. Int. 27:1995;1-22
50. Ebadi M., Leuschen M.P., el Refaey H., Hamada F.M., Rojas P. The antioxidant properties of zinc and metallothionein. Neurochem. Int. 29:1996;159-166
51. Ebadi M., Hiramatsu M., Burke W.J., Folks D.G., el-Sayed M.A. Metallothionein isoforms provide neuroprotection against 6-hydroxydopamine- generated hydroxyl radicals and superoxide anions. Proc. West. Pharmacol. Soc. 41:1998;155-158
52. El Refaey H., Ebadi M., Kuszynski C.A., Sweeney J., Hamada F.M., Hamed A. Identification of metallothionein receptors in human astrocytes. Neurosci. Lett. 15:1997;131-134
53. Engerson T.D., McKelvy T.G., Rhyme D.B., Boggio E.B., Snyder S.J., Jones H.P. Conversion of xanthine dehydrogenase to oxidase in ischemic rat tissues. J. Clin. Invest. 79:1987;1564-1570
54. Esterbrauer H., Zollner H., Schaur R.J. Aldehydes formed by lipid peroxidation: mechanisms of formation, occurrence and determination. Vigo-Pelfrey C.D. Membrane Lipid Oxidation. vol. 1:1990;239-268 CRC Press, Boca Raton, FL
55. Fahn S., Cohen G. The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann. Neurol. 32:1992;804-812
56. Figlewicz D.A., Orrell R.W. The genetics of motor neuron diseases. Amyotroph. Lateral Scler. Other Mot. Neuron Disord. 4:2003;225-231
57. Fiskum G., Starkov A., Polster B.M., Chinopoulos C. Mitochondrial mechanisms of neural cell death and neuroprotective interventions in Parkinson's disease. Ann. N.Y. Acad. Sci. 991:2003;111-119
58. Forrest G.L., Akman S., Doroshow J., Rivera H., Kaplan W.D. Genomic sequence and expression of a cloned human carbonyl reductase gene with daunorubicin reductase activity. Mol. Pharmacol. 40:1991;502-507
59. Frei B. Ascorbic acid protects lipids in human plasma and low density lipoprotein against oxidative damage. Am. J. Clin. Nutr. 54:1991;1113S-1118S
60. Frei B., Stocker R., Ames B.N. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc. Natl. Acad. Sci. U. S. A. 85:1988;9748-9752
61. Friedlich A.L., Butcher L.L. Involvement of oxygen free radicals in β-amyloidosis: an hypothesis. Neurobiol. Aging. 15:1994;443-455
62. Gau W., Ploschke H.J., Wunsche M.S. Identification of xanthophyll fatty acid esters from marigold flowers obtained by HPLC and Craig counter-current distribution. J. Chromatogr., A. 262:1983;277-284
63. Greenwald R.A. Superoxide dismutase and catalase as therapeutic agents for human diseases: a critical review. Free Radic. Biol. Med. 8:1990;201-209
64. Gurney M.E., Pu H., Chiu A.Y., Canto M.C.D., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H., Chen W., Zzhai P., Sufit R.L., Siddique T. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science. 264:1994;1772-1775
65. Gutteridge J.M.C. Iron promoters of the Fenton reaction and lipid peroxidation can be released from haemoglobin by peroxides. FEBS Lett. 20:1986;291-295
66. Gutteridge J.M.C. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin. Chem. 41:1995;1819-1828
67. Halliwell B. Antioxidants: the basics. What they are and how to evaluate them. Adv. Pharmacol. 38:1997;3-20
68. Halliwell B. Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging. 18:2001;685-716
69. Halliwell B., Gutteridge J.M.C. Free Radicals in Biology and Medicine. Second ed.:1989;Clarendon Press, Oxford
70. Halliwell B., Gutteridege J.M.C. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol. 186:1990;1-85
71. Halliwell B., Gutteridge J.M.C., Aruoma O.I. The deoxyribose method: a simple "test tube" assay for determination of rate constants for reactions of hydroxyl radicals. Methods Enzymol. 233:1987;215-219
72. Hao R., Cerutis D.R., Blaxall H.S., Rodrigues-Sierra J.F., Pfeiffer R.F., Ebadi M. Distribution of zinc metallothionein I mRNA in rat brain using in situ hybridization. Neurochem. Res. 19:1994;761-767
73. Hashimoto M., Rockenstein E., Crews L., Masliah E. role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases. Neuromol. Med. 4:2003;21-36
74. Heinonen M.I., Ollilainen V., Linkola E.K., Varo P.T., Koivistoinen P.E. Carotenoids in Finnish foods: vegetables fruits and berries. J. Agric. Food Chem. 37:1989;655-659
75. Hensley K., Carney J.M., Mattson M.P., Aksenova M., Harris M., Wu J.F., Floyd R.A., Butterfield D.A. A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 91:1994;3270-3274
76. Humpel C., Hoffer B., Strömberg I., Bektesh S., Collins F., Olson L. Neurons of the hippocampal formation express glial cell line-derived neurotrophic factor messenger RNA in response to kainate-induced excitation. Neuroscience. 59:1994;791-795
77. Iannello R.C., Crack P.J., De Haan J.B., Kola I. Oxidative stress and neural dysfunction in Down syndrome. J. Neural Transm. 57:1999;257-268
78. Inoue M., Sato E.F., Nishikawa M., Park A.M., Kira Y., Imada I., Utsumi K. Mitochondrial generation of reactive oxygen species and its role in aerobic life. Curr. Med. Chem. 10:2003;2495-2505
79. Irani K., Xia Y., Zweier J.L., Sollott S.J., Der C.J., Fearon E.R., Sundaresan M., Finkel T., Goldschmidt-Clermont P.J. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science. 275:1997;1649-1652
80. Jafari-Schluep H.F., Khoris J., Mayeux-Portas V., Hand C., Rouleau G., Camu W. Superoxide dismutase 1 gene abnormalities in familial amyotrophic lateral sclerosis: phenotype/genotype correlations. The French experience and review of the literature. Rev. Neurol. 160:2004;44-50
81. Jellinger K.A. General aspects of neurodegeneration. J. Neural Transm., Suppl. 65:2003;101-144
82. Jenner P. Oxidative stress in Parkinson's disease. Ann. Neurol. 53(Suppl. 3):2003;S26-S38
83. Jordan J., Cena V., Prehn J.H. Mitochondrial control of neuron death and its role in neurodegenerative disorders. J. Physiol. Biochem. 59:2003;129-141
84. Juliano L., Pedersen J.Z., Rotilio G., Ferro D., Violi F. A potent chain-breaking antioxidant activity of the cardiovascular drug dipyridamole. Free Radic. Biol. Med. 18:1995;239-247
85. Kanofsky J.R., Sima P.D. Singlet-oxygen generation at gas-liquid interfaces: a significant artifact in the measurement of singlet oxygen yields from ozone-biomolecule reactions. Photochem. Photobiol. 58:1993;335-340
86. Kaur H., Halliwell B. Detection of hydroxyl radicals by aromatic hydroxylation. Methods Enzymol. 233:1994;67-82
87. Khachik F., Beecher G.R., Whittaker N.F. Separation, identification and quantification of the major carotenoids and chlorophyll constituents in extracts of several green vegetables by liquid chromatography. J. Agric. Food Chem. 34:1986;603-616
88. Klaidman L.K., Yang J., Chang M.L., Adams J.D. Jr. Recent developments on the role of mitochondria in poly (ADP-ribose) polymerase inhibition. Curr. Med. Chem. 10:2003;2669-2678
89. Kumari M.V., Hiramatsu M., Ebadi M. Free radical scavenging actions of metallothionein isoforms I and II. Free Radic. Res. 29:1998;93-101
90. Lemieux N., Malfoy B., Forrest G.L. Human carbonyl reductase (CBR) localized to band 21q22.1 by high-resolution fluorescence in situ hybridization displays gene dosage effects in trisomy 21 cells. Genomics. 15:1993;169-172
91. Lemke M., Ames B.N., Faden A.I. Decrease in tissue levels of ubiquinol-9 and -10, ascorbate and α-tocopherol following spinal cord impact trauma in rats. Neurosci. Lett. 108:1990;201-206
92. Levesque G., Murthy M.R.V. Alzheimer's disease: what we have learned from gene analysis. Marwah J., Teitelbaum H. Advances in Neurodegenerative Disorders. Alzheimer's and Aging. vol. 2:1998;49-70 Prominent Press, Arizona
93. Martinez-Ruiz A., Lamas L. S-nitrosylation: a potential new paradigm in signal transduction. Cardiovasc. Res. 62:2004;43-52
94. Maxwell S.R.J. Prospects for the use of antioxidant therapies. Drugs. 49:1995;345-361
95. McCord J.M., Ormar B.A. Sources of free radicals. Toxicol. Ind. Health. 9:1993;23-37
96. Melisi D., Troiani T., Damiano V., Tortora G., Ciardiello F. Therapeutic integration of signal transduction targeting agents and conventional anti-cancer treatments. Endocr.-Relat. Cancer. 11:2004;51-68
97. Melov S., Hinerfeld D., Esposito L., Wallace D.C. Multi-organ characterization of mitochondrial genomic rearrangements in ad libitum and caloric restricted mice show striking somatic mitochondrial DNA rearrangements with age. Nucleic Acids Res. 25:1997;974-982
98. Mink R.B., Dutka A.J., Kumaroo K.K., Hallenbeck J.M. No conversion of xanthine dehydrogenase to oxidase in canine cerebral ischemia. Am. J. Physiol. 259:1990;H1655-H1659
99. Miuzi T., Kinouchi H., Chan P.H. Depletion of brain glutathione by buthionine sulfoxamine enhances cerebral ischemic injury in rats. Am. J. Physiol. 262:1992;H313-H317
100. Modell B., Letsky E.A., Flynn D.M., Peto R., Wootherall D.J. Survival and desferrioxamine in thalassaemia major. BMJ. 284:1982;1081-1084
101. Moncada S., Higgs E.A. Endogenous nitric oxide: physiology, pathology and clinical relevance. Eur. J. Clin. Investig. 21:1991;361-374
102. Muller D.P.R. Neurological disease. Sies H. Antioxidants in Disease Mechanisms and Therapy. 1997;557-580 Academic Press, New York
103. Murthy M.R.V. Interactions between chromosome 21 and the rest of the human genome in Down syndrome: role of oxidative stress and antioxidant enzymes. Marwah J., Kanthasamy A. Antioxidants and Free Radicals in Health and Disease. 2001;213-236 Prominent Press, Arizona
104. Murthy M.R.V. Coenzyme-Q and related isoprenoid compounds: biosynthesis, regulation, functions and biomedical implications. Ebadi M., Marwah J., Chopra R. Mitochondrial Ubiquinone (Coenzyme Q-10). 2001;231-346 Prominent Press, Arizona
105. Murthy M.R.V., Levesque G. Down syndrome: free radicals and antioxidant processes. Marwah J., Kanthasamy A. Antioxidants and Free Radicals in Health and Disease. 2001;237-260 Prominent Press, Arizona
106. Murthy M.R.V., Julien P., Gagné C. Molecular pathobiology of the lipoprotein lipase gene. Pharmacol. Ther. 70:1996;101-135
107. Murthy M.R.V., Julien P., Singh P., Levy E. Human lipoprotein lipase deficiency: does chronic dyslipidemia lead to increased oxidative stress and mitochondrial DNA damage in blood cells? Acta Biochim. Pol. 43:1996;227-240
108. Niki E., Noguchi N., Gotoh N. Dynamics of lipid peroxidation and its inhibition by antioxidants. Biochem. Soc. Trans. 21:1993;313-317
109. Ogawa N., Mori A. Parkinson's disease, dopamine and free radicals. Cutler R.G., Packer L., Bertram J., Mori A. Oxidative Stress and Aging. 1995;303-308 Birkhauser Verlag, Basel
110. Olanow C.W. A radical hypothesis for neurodegeneration. Trends Neurosci. 16:1993;439-444
111. Opara E.C. Role of oxidative stress in the etiology of type 2 diabetes and the effect of antioxidant supplementation on glycemic control. J. Investig. Med. 52:2004;19-23
112. Packer L.E. Oxygen radicals in biological systems. Methods in Enzymology. 1984;105 Academic Press, New York
113. Packer L.E. Oxygen radicals in biological systems: Part C. Methods in Enzymology. 1994;233 Academic Press, New York
114. Packer L., Glazer A.N.E. Oxygen radicals in biological systems: Part B. (Oxygen radicals and antioxidants). Methods in Enzymology. 1990;186 Academic Press, New York
115. Packer J.E., Slater T.F., Wilson R.L. Direct observation of a free radical interaction between vitamin E and vitamin C. Nature. 278:1979;737-738
116. Palmer H.J., Paulson K.E. Reactive oxygen species and antioxidants in signal transduction and gene expression. Nutr. Rev. 55:1997;353-361
117. Paradis E., Clément S., Julien P., Murthy M.R.V. Lipoprotein lipase affects the survival and differentiation of neural cells exposed to very low density lipoprotein. J. Biol. Chem. 278:2003;9698-9705
118. Paradis E., Clavel S., Julien P., Murthy M.R.V., de Bilbao F., Arsenijevic D., Giannakopoulos P., Vallet P., Richard D. Lipoprotein lipase and endothelial lipase expression in mouse brain: regional distribution and selective induction following kainic acid-induced lesion and focal cerebral ischemia. Neurobiol. Dis. 15:2004;312-325
119. Parker W.D., Filley C.M., Parks J.K. Cytochrome oxidase deficiency in Alzheimer's disease. Neurology. 40:1990;1302-1303
120. Parnham M.J., Leyck S., Graf E.E.A. The pharmacology of ebselen. Agents Actions. 32:1991;4-9
121. Pieri C., Marra M., Moroni F., Decchioni R., Marcheselli F. Melatonin: a peroxy radical scavenger more effective than vitamin E. Life Sci. 55:1994;271-276
122. Pierrefiche G., Topall G., Coubain G., Henriet I., Laborit H. Antioxidant activity of melatonin in mice. Res. Commun. Chem. Pathol. Pharmacol. 80:1994;211-223
123. Poirier J., Barbeau A. A catalyst function for MPTP in superoxide formation. Biochem. Biophys. Res. Commun. 131:1985;1284-1289
124. Poulsen K.T., Armanini M.P., Klein R.D., Hynes M.A., Philips H.S., Rosenthal A. TGFB2 and TGFB3 are potent survival factors for midbrain dopaminergic neurons. Neuron. 13:1994;1245-1252
125. Powis G., Gasdaska J.R., Baker A. Redox signaling and the control of cell growth and death. Adv. Pharmacol. 38:1997;329-359
126. Rao C.V., Rivenson A., Simi B., Reddy B.S. Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res. 55:1995;259-266
127. Reiter R.J. The aging pineal gland and its physiological consequences. BioEssays. 14:1992;169-175
128. Reiter R.J. Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB J. 9:1995;526-533
129. Reiter R.J. The pineal gland and melatonin in relation to aging: a summary of the theories and of the data. Exp. Gerontol. 30:1995;199-212
130. Reiter R.J., Poeggeler B., Tan D.X., Chen L.D., Manchester L.C., Guerrero J.M. Antioxidant capacity of melatonin: a novel action not requiring a receptor. Neuro Endocrinol. Lett. 15:1993;103-116
131. Reiter R.J., Tan D.X., Poeggeler B., Menendez-Palaez A., Chen L.D., Saarela S. Melatonin as a free radical scavenger: implications for aging and age-related diseases. Ann. N.Y. Acad. Sci. 719:1994;1-12
132. Rojas P., Cerutis D.R., Happe H.K., Murrin L.C., Hao R., Pfeiffer R.F., Ebadi M. 6-Hydroxydopamine-mediated induction of rat brain metallothionein I mRNA. Neurotoxicology. 17:1996;323-334
133. Rosen D.R., Siddique T., Patterson D., Figglewicz D.A., Sapp P.H.A., Donaldson D., Goto J., O'Regan J.P., Deng H., Rohmani Z., Krizus A., McKenna-Yasek D., Cayabyab A., Gaston S.M., Berger R., Tanzi R.E., Halperin J.J., Hertzfeldt B., Van den Berg R., Hung W., Bird T., Deng G., Mulder D.W., Smyth C., Laing N.G., Soriano E., Pericak-Vance M.A., Haines J., Rouleau G.A., Gusella J.S., Horvitz H.R., Brown R.H. Jr. Mutations in Cu/Zn superoxidase dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 362:1993;59-62
134. Rothstein J.D., Bristol L.A., Hostler B., Brown R.H.J., Kuncl R.W. Chronic inhibition of superoxide dismutase produces apoptotic death of spinal neurons. Proc. Natl..Acad. Sci. U. S. A. 91:1994;4155-4159
135. Sadek H.A., Nulton-Persson A.C., Szweda P.A., Szweda L.I. Cardiac ischemia/reperfusion, aging, and redox-dependent alterations in mitochondrial function. Arch. Biochem. Biophys. 420:2003;201-208
136. Sastre J., Pallardo F.V., Vina J. The role of mitochondrial oxidative stress in aging. Free Radic. Biol. Med. 35:2003;1-8
137. Saunders R.D., Dugan L.L., Demeduik P., Means E.D., Horrocks L.A., Anderson D.K. Effects of methylprednisolone and the combination of α-tocopherol and selenium on arachidonic acid metabolism and lipid peroxidation in traumatized spinal cord tissue. J. Neurochem. 49:1987;24-31
138. Shafik H.M., Au W.W., Legator M.S. Chromosomal radiosensitivity of Down's syndrome lymphocytes at different stages of the life cycle. Hum. Genet. 78:1988;71-75
139. Shapira A.H.V., Mann V.M., Cooper J.M., Krige D., Jenner P.J., Marsden C.D. Mitochondrial function in Parkinson's disease. Ann. Neurol. 32:1992;S116-S124. (Suppl.)
140. Shapiro B.L. The Down syndrome critical region. J. Neural Transm. 57:1999;41-50
141. Shida C.S., Castrucci A.M.L., Lamy-Freund M.T. High melatonin solubility in aqueous medium. J. Pineal Res. 16:1994;198-201
142. Shiraga H., Pfeiffer R.F., Ebadi M. The effects of 6-hydroxydopamine and oxidative stress on the level of brain metallothionein. Neurochem. Int. 23:1993;561-566
143. Sies H.E. Oxidative Stress: Oxidants and Antioxidants. 1991;Academic Press, London
144. Sinet P.M., Rahmani Z., Theophile D., Chettouh Z., Blouin J.L., Prieur M., Noel B., Pangalos C., Mattei J.F., Kraus J., Delabar J.M. Definition of 7 minimal regions on chromosome 21 involved in the pathogenesis of 23 features of Down syndrome. Cytogenet. Cell Genet. 58:1991;2040
145. Singh P.J., Julien P., Mirault M.E., Murthy M.R.V. Amplification of the entire mitochondrial DNA by polymerase chain reaction in two large overlapping segments. Anal. Biochem. 225:1995;152-155
146. Singh P.J., Julien P., Mirault M.E., Murthy M.R.V. Quick preparation of mitochondrial DNA fractions free from nuclear DNA for polymerase chain reaction amplification. Anal. Biochem. 225:1995;155-157
147. Singh P.J., Legault J., Tremblay A., Julien P., Murthy M.R.V., Mirault M.E. PCR analysis of mitochondrial DNA from normal and transgenic glutathione peroxidase mice. Cutler R.G., Packer L., Bertram J., Mori A. Oxidative Stress and Aging. 1995;179-180 Berkhauser Verlag, Basel, Switzerland
148. Smith C.D., Carney J.M., Starke-Reed P.E., Oliver C.N., Stadtman E.R., Floyd R.A., Markesbery W.R. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 88:1991;10540-10543
149. Smith M.A., Taneda S., Richey P.L., Miyata S., Yan S.D., Stern D., Sayre L.M., Monnier V.M., Perry G. Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc. Natl. Acad. Sci. U. S. A. 91:1994;5710-5714
150. Snyder S.H., D'Amato R.J. MPTP: a neurotoxin relevant to the pathophysiology of Parkinson's disease: the 1985 George C. Cotzias lecture. Neurology. 36:1986;250-258
151. Sohal R.S., Ku H.H., Agarwal S., Forster M.J., Lal H. Oxidative damage, mitochondrial oxidant generation and antioxidant defenses during aging and in response to food restriction in the mouse. Mech. Ageing Dev. 74:1994;121-133
152. Soong N.W., Hinton D.R., Cortopassi G., Arnheim N. Mosaicism for a specific somatic mitochondrial DNA mutation in adult human brain. Nat. Genet. 2:1992;318-323
153. Srinivasan V. Melatonin, oxidative stress and neurodegenerative diseases. Ind. J. Exp. Med. 40:2002;668-679
154. Srinivas L., Shalini V.K., Shylaja M. Turmerin: a water soluble antioxidant peptide from turmeric (Curcuma longa). Arch. Biochem. Biophys. 292:1992;617-623
155. Stadtman E.R. Protein oxidation and aging. Science. 257:1992;1220-1224
156. Strauss, W.M. (1990) Preparation of Genomic DNA from Mammalian Tissue. Current Protocols. Greene Pub. Associates and Wiley-Interscience, Wiley, New York.
157. Sun Y., Oberly L.W. Redox regulation of transcriptional activators. Free Radic. Biol. Med. 21:1996;335-348
158. Szibor M., Holtz J. Mitochondrial ageing. Basic Res. Cardiol. 98:2003;210-218
159. Tan D.X., Chen L.D., Poeggeler B., Manchester L.C., Reiter R.J. Melatonin: a potent endogenous hydroxyl radical scavenger. Endocr. J. 1:1993;57-60
160. Tan D.X., Reiter R.J., Chen L.D., Poeggeler B., Manchester L.C., Barlow-Walden L.R. Both physiological and pharmacological levels of melatonin reduce DNA adduct formation induced by the carcinogen safrole. Carcinogenesis. 15:1994;215-218
161. Tomac A., Lindqvist E., Lin L.F.H., Ögren S.O., Young D., Hoffer B.J., Olson L. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature (Lond.). 373:1995;335-339
162. Tonucci L.H., Holden J.M., Beecher G.R., Khachik F., Davis C.S., Mulokozi G. Carotenoid contents of thermally processed tomato-based food products. J. Agric. Food Chem. 43:1995;579-586
163. Traystman R.J., Kirsch J.R., Koehler R.C. Oxygen radical mechanisms of brain injury following ischemia and reperfusion. J. Appl. Physiol. 71:1991;1185-1195
164. Vanhoutte P.M. Endothelium-dependent hyperpolarizations: the history. Pharmacol. Res. 49:2004;503-508
165. von Sonntag C. The Chemical Basis of Radiation Biology. 1988;Taylor and Francis, London
166. Wahlgren N.G., Ahmed N. Neuroprotection in cerebral ischaemia: facts and fancies - the need for new approaches. Cerebrovasc. Dis. 17(Suppl. 1):2004;153-166
167. Wallace D.C. Mitochondrial genetics: a paradigm for aging and degenerative diseases? Science. 256:1992;628-632
168. Wallace D.C. Mouse models for mitochondrial disease. Am. J. Med. Genet. 106:2001;71-93
169. Wang X., Lo E.H. Triggers and mediators of hemorrhagic transformation in cerebral ischemia. Mol. Neurobiol. 28:2003;229-244
170. Watanabe T., Nakamura T. The effects of linoleate hydroperoxide on respiration and oxidative phosphorylation of rat liver mitochondria. J. Biochem. (Tokyo). 86:1979;1041-1047
171. Winyard P.G., Blake D.R. Antioxidants, redox-regulated transcription factors, and inflammation. Adv. Pharmacol. 38:1997;403-421
172. Yan S.D., Chen X., Schmidt A.M., Brett J., Godman G., Zou Y.S., Scott C.W., Caputo C., Frappier T., Smith M.A., Perry G., Yen S.H., Stern D. Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress. Proc. Natl. Acad. Sci. U. S. A. 91:1994;7787-7791
173. Zhang Y., Marcillat O., Giulivi C., Ernster L., Davies K.J.A. The oxidative inactivation of mitochondrial electron transport chain components and ATPase. J. Biol. Chem. 265:1990;16330-16336
174. Zhao W., Richardson J.S., Mombourquette M.J., Weil J.A. An in vitro EPR study of the free-radical scavenging actions of the lazaroid antioxidants U-74500A and U-78517F. Free Radic. Biol. Med. 19:1995;21-30